Gout can flare after starting allopurinol because lowering uric acid levels can temporarily trigger attacks as the body adjusts to treatment. Allopurinol reduces uric acid production, but it does not remove existing uric acid crystals immediately. As treatment continues, the risk of future attacks usually decreases. Early flares do not necessarily mean the medicine is failing or that treatment needs to stop.
Why can allopurinol trigger a gout attack at first?
Allopurinol is a uric acid-lowering medicine used to prevent gout attacks over time. It works by blocking an enzyme involved in uric acid production. However, people with gout may already have uric acid crystals deposited in and around their joints. Lowering uric acid levels changes the conditions surrounding these deposits, and changes during early treatment can temporarily increase the likelihood of a flare.
During an attack, the immune system reacts to uric acid crystals, causing inflammation. This can lead to sudden joint pain, warmth, swelling, redness, and tenderness. Even when blood uric acid levels begin to fall, existing crystal deposits may remain. As a result, a person can experience a painful attack while taking a medicine that is intended to prevent future attacks.
MedlinePlus explains that allopurinol may increase the number of gout attacks during the first few months of treatment, even though it eventually helps prevent them. This early increase is a recognized part of starting uric acid-lowering therapy.
How long can gout flares continue after starting allopurinol?
Gout attacks may occur during the first few months after starting allopurinol. The exact duration and frequency vary from person to person. Some people experience an early flare followed by longer periods without symptoms, while others have repeated attacks during the initial months of treatment.
The risk of flares generally decreases as uric acid levels remain below the treatment target and existing crystal deposits gradually dissolve. This process takes time, so pain may continue to occur even when blood test results are improving. The number of attacks alone cannot show whether treatment is working; follow-up uric acid measurements and the overall pattern of symptoms are also important.
The NHS guidance on allopurinol notes that attacks may be more likely when treatment first begins. It also advises patients not to stop the medicine unless their doctor tells them to.
Does a gout flare mean allopurinol is not working?
No. An early gout attack does not automatically mean allopurinol has failed. The medicine is intended to lower uric acid over time, rather than provide immediate pain relief during an attack. It may take several months or longer to experience its full preventive benefit.
Healthcare professionals assess the response to treatment by checking uric acid levels, reviewing the dose, considering how consistently the medicine is taken, and evaluating the frequency of attacks. If uric acid remains above the recommended target, the prescribed dose may need gradual adjustment. A flare can therefore occur even when treatment is progressing appropriately.
The American College of Rheumatology's gout management guideline recommends a treat-to-target approach, with allopurinol doses adjusted according to repeated blood uric acid measurements. For most people receiving urate-lowering treatment, the target is below 6 mg/dL, although treatment decisions should account for individual circumstances.
What makes early flares more likely?
Several factors can influence the likelihood of an attack during the early stages of allopurinol treatment. These include the amount of uric acid crystal buildup already present, the uric acid level before treatment, and how quickly levels change during treatment.
- Existing crystal deposits: A larger burden of uric acid crystals can take longer to clear, leaving the joints vulnerable to inflammation during early treatment.
- Starting or increasing the dose: Changes in uric acid levels during treatment initiation or dose adjustment can be associated with flares.
- Not taking preventive anti-inflammatory medicine: Without suitable preventive treatment, some people are more likely to experience attacks when beginning uric acid-lowering therapy.
- Interrupting treatment: Missing doses or stopping allopurinol without medical guidance can interfere with long-term uric acid control.
These factors do not predict with certainty who will experience an attack. Your clinician can review your treatment history, blood results, other medicines, and kidney function to determine whether any changes are appropriate.
How can you reduce gout flares when starting allopurinol?
Preventing early attacks is an important part of gout treatment. Allopurinol lowers uric acid over time, while separate anti-inflammatory medicines may be used to reduce the chance of flares during the adjustment period.
Use preventive medicine when prescribed
Your healthcare professional may prescribe colchicine, a nonsteroidal anti-inflammatory drug (NSAID), or a corticosteroid to help prevent attacks when allopurinol is started. The choice depends on factors such as kidney function, other health conditions, existing medicines, and the risk of side effects.
The American College of Rheumatology guideline recommends anti-inflammatory preventive treatment when starting uric acid-lowering therapy, generally for at least three to six months, with continued assessment if attacks persist. The duration and choice of medicine should be individualized. Do not start an anti-inflammatory drug or change a prescribed dose without checking that it is suitable for you.
Start with a low dose and adjust gradually
Allopurinol is commonly started at a low dose and increased gradually according to blood uric acid results and individual tolerance. The appropriate starting dose depends on clinical circumstances, including kidney function. Gradual dose adjustment helps manage treatment safely while working toward the uric acid target.
A low starting dose does not necessarily mean that the final dose will also be low. Some people need a higher maintenance dose to achieve adequate uric acid control. Dose changes should be guided by a healthcare professional rather than made independently in response to a flare.
Continue treatment as directed
If a gout attack occurs after starting allopurinol, do not stop or reduce the medicine on your own. Stopping treatment can disrupt uric acid control and may contribute to further problems. Contact your healthcare professional for advice on managing the attack and deciding whether any adjustment is necessary.
Allopurinol prevents future attacks but is not designed to relieve the pain and inflammation of an acute flare. Your clinician may recommend a separate treatment for the attack while your long-term uric acid-lowering medicine continues.
Keep up with monitoring and everyday habits
Follow-up blood tests help determine whether uric acid levels are reaching the treatment target. Your clinician may also review kidney function, other medicines, and the pattern of attacks. Drinking enough water, limiting alcohol, and following a balanced eating pattern may support overall gout management, but these measures do not replace prescribed treatment or guarantee that early flares will be prevented.
When should a flare or other symptoms be checked?
Contact your healthcare professional if attacks continue, become more frequent, interfere with daily activities, or do not improve with the treatment recommended for you. A clinician can assess whether the symptoms fit the expected pattern of a gout flare and whether treatment needs review.
A hot, swollen joint is not always caused by gout. If the joint symptoms are new or unusual, particularly when accompanied by fever or feeling generally unwell, seek urgent medical assessment because a joint infection can cause similar symptoms and requires prompt treatment.
Allopurinol can also cause rare but serious hypersensitivity reactions. Stop taking it and seek urgent medical attention if you develop a new rash, blistering or peeling skin, sores in the mouth or eyes, or swelling of the face or throat. Do not assume that these symptoms are part of an ordinary gout flare.
What should you expect as treatment continues?
Early flares can be discouraging, especially when starting treatment with the goal of avoiding painful attacks. However, the main purpose of allopurinol is to lower uric acid over the long term, allowing crystal deposits to gradually dissolve and reducing the likelihood of future attacks.
With appropriate dosing, preventive treatment when indicated, and regular monitoring, many people achieve better gout control over time. An early flare is a reason to review symptom management and follow the treatment plan, not necessarily a sign that allopurinol is ineffective.